Browse Studies — Arctuva

Phase 4

Pragmatic Randomized Trial Evaluating Dosage of Ceftriaxone for Community-Acquired Pneumonia Outside the Intensive Care Unit

Aim: Demonstrate the equivalent efficacy and superior safety of Ceftriaxone 1 gram daily compared with Ceftriaxone 2 grams daily among hospitalized patients wi…

Community Acquired Pneumonia (CAP)

Estimated

~$10 – $6,250

University of Maryland, BaltimoreNCT07537413

Phase 4

Short Versus Standard of Care Antibiotic Duration for Hospitalized Children With Uncomplicated Community-acquired Pneumonia: a Non-inferiority, Randomized Controlled Trial.

The goal of this open label, randomized, non-inferiority clinical trial is to compare the treatment success of a 5 day antibiotic course versus a standard anti…

Community Acquired Pneumonia in Children

Estimated

~$10 – $6,250

Medical College of WisconsinNCT06494072

Observational

Comparing Antibiotic Treatment Strategies for Children With Community-Acquired Pneumonia in Outpatient Settings (Safety-Net Antibiotic Prescribing to Manage Pediatric Pneumonia [STAMPP])

The goal of this clinical trial is to determine if a "watch and wait" antibiotic strategy, called Safety Net Antibiotic Prescribing (SNAP), can safely reduce u…

Community Acquired Pneumonia (CAP)Community Acquired Pneumonia

Estimated

~$10 – $6,250

Ann & Robert H Lurie Children's Hospital of ChicagoNCT06986148

Phase 1

A Phase 1b Study to Assess the Safety, Tolerability and Pharmacokinetics of OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis

OPT101-100-40 is a multicenter, randomized, placebo-controlled, multiple-ascending-dose, sequential-group, investigator- and participant-blinded, sponsor-unbli…

SepsisCommunity Acquired Pneumonia (CAP)

Estimated

~$10 – $8,750

Op-T LLCNCT06669403